Nemedic

Press · Deployments & partnerships

Nemedic and Aerin Medical Launch Patient-Access Pilot for Nasal Airway Treatment Candidates

An executed vendor agreement with a nasal airway device company produced a measured patient-conversion pilot.

March 1, 2021

WESTFIELD, Ind. — Nemedic and Aerin Medical have launched a patient-access pilot connecting patients with nasal airway obstruction to physicians who treat it.

Under a vendor agreement executed in November 2020, Nemedic built a patient-facing pathway for candidates for Aerin's VivAer treatment and reported conversion results through the pilot period.

The engagement is an early instance of a pattern that recurs across Nemedic's history: the barrier to specialty procedural care is usually not clinical judgment or device availability, but the administrative distance between a patient's first inquiry and a scheduled visit.

About Nemedic, Inc. — Nemedic is a physician-founded healthcare technology company building AI infrastructure and autonomous administrative workflow for procedural healthcare. Its platform, Blue (useBlue.ai), runs alongside existing electronic health records to take on referral intake, patient engagement, prior-authorization readiness and clinical documentation. Nemedic was founded by otolaryngologist Bradford G. Bichey, MD, MPH, and is based in Westfield, Indiana. Its patient engagement and prequalification architecture is protected by U.S. Patent No. 12,592,322. Learn more at useblue.ai.

Media contact: press@nemedic.com